Suchonwanit Poonkiat, Thammarucha Sasima, Leerunyakul Kanchana
Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Drug Des Devel Ther. 2019 Aug 9;13:2777-2786. doi: 10.2147/DDDT.S214907. eCollection 2019.
Minoxidil was first introduced as an antihypertensive medication and the discovery of its common adverse event, hypertrichosis, led to the development of a topical formulation for promoting hair growth. To date, topical minoxidil is the mainstay treatment for androgenetic alopecia and is used as an off-label treatment for other hair loss conditions. Despite its widespread application, the exact mechanism of action of minoxidil is still not fully understood. In this article, we aim to review and update current information on the pharmacology, mechanism of action, clinical efficacy, and adverse events of topical minoxidil.
米诺地尔最初作为一种抗高血压药物被引入,其常见不良事件多毛症的发现促使了一种促进头发生长的局部用制剂的研发。迄今为止,局部用米诺地尔是雄激素性脱发的主要治疗方法,并被用作其他脱发病症的非标签治疗药物。尽管其应用广泛,但米诺地尔的确切作用机制仍未完全明确。在本文中,我们旨在回顾和更新关于局部用米诺地尔的药理学、作用机制、临床疗效和不良事件的当前信息。